199 related articles for article (PubMed ID: 35586707)
1.
Kwon A; Ibrahim I; Le T; Jaso JM; Weinberg O; Fuda F; Chen W
Leuk Res Rep; 2022; 17():100323. PubMed ID: 35586707
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
Ouyang Y; Qiao C; Chen Y; Zhang SJ
Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
[TBL] [Abstract][Full Text] [Related]
3. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
Qian Y; Chen Y; Li X
Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
[TBL] [Abstract][Full Text] [Related]
4. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
Kim SY; Song IC; Kim J; Kwon GC
Ann Diagn Pathol; 2024 Aug; 71():152317. PubMed ID: 38642470
[TBL] [Abstract][Full Text] [Related]
5. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
[TBL] [Abstract][Full Text] [Related]
6. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
Pardanani A; Lasho TL; Laborde RR; Elliott M; Hanson CA; Knudson RA; Ketterling RP; Maxson JE; Tyner JW; Tefferi A
Leukemia; 2013 Sep; 27(9):1870-3. PubMed ID: 23604229
[TBL] [Abstract][Full Text] [Related]
7. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
Szuber N; Orazi A; Tefferi A
Am J Hematol; 2024 Jul; 99(7):1360-1387. PubMed ID: 38644693
[TBL] [Abstract][Full Text] [Related]
8. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
Adam FC; Szybinski J; Halter JP; Cantoni N; Wenzel F; Leonards K; Brkic S; Passweg JR; Touw I; Maxson JE; Meyer SC
Curr Oncol; 2022 Feb; 29(2):805-815. PubMed ID: 35200567
[TBL] [Abstract][Full Text] [Related]
9. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
[TBL] [Abstract][Full Text] [Related]
10. Myeloid Disease with the CSF3R T618I Mutation after CLL.
Couto ME; Bizarro S; Sousa D; Domingues N; Oliveira I; Martins G; Teixeira MR; Mariz M
Case Rep Hematol; 2020; 2020():6670965. PubMed ID: 33414971
[TBL] [Abstract][Full Text] [Related]
11. ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.
Elliott MA; Pardanani A; Hanson CA; Lasho TL; Finke CM; Belachew AA; Tefferi A
Am J Hematol; 2015 Jul; 90(7):653-6. PubMed ID: 25850813
[TBL] [Abstract][Full Text] [Related]
12. CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes.
Bezerra ED; Lasho TL; Finke CM; Saliba AN; Elliott MA; Pardanani AD; Gangat N; Mangaonkar AA; Ketterling RP; Tefferi A; Solary E; Patnaik MM
Blood Cancer J; 2021 Mar; 11(3):54. PubMed ID: 33707412
[No Abstract] [Full Text] [Related]
13. CSF3R T618I mutant myelodysplastic/myeloproliferative neoplasm in the elderly: An age-related disease with unfavorable prognosis.
Zhang X; Ghiuzeli C; Jou E; Hsu P; Kolitz J; Brody JP
Leuk Res Rep; 2022; 17():100334. PubMed ID: 35795468
[TBL] [Abstract][Full Text] [Related]
14. Mutational landscape of chronic myelomonocytic leukemia in Chinese patients.
Nie Y; Shao L; Zhang H; He CK; Li H; Zou J; Chen L; Ji H; Tan H; Lin Y; Ru K
Exp Hematol Oncol; 2022 May; 11(1):32. PubMed ID: 35610628
[TBL] [Abstract][Full Text] [Related]
15. Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia.
Cui Y; Tong H; Du X; Li B; Gale RP; Qin T; Liu J; Xu Z; Zhang Y; Huang G; Jin J; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
Exp Hematol Oncol; 2015; 4():14. PubMed ID: 26019984
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia.
Yun JW; Yoon J; Jung CW; Lee KO; Kim JW; Kim SH; Kim HJ
J Clin Lab Anal; 2020 Feb; 34(2):e23064. PubMed ID: 31692115
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report.
Pelkey LJ; Graham DM; Zakem MH; Muza-Moons MM
Cureus; 2022 Feb; 14(2):e22422. PubMed ID: 35228982
[TBL] [Abstract][Full Text] [Related]
18. Age-related mutations and chronic myelomonocytic leukemia.
Mason CC; Khorashad JS; Tantravahi SK; Kelley TW; Zabriskie MS; Yan D; Pomicter AD; Reynolds KR; Eiring AM; Kronenberg Z; Sherman RL; Tyner JW; Dalley BK; Dao KH; Yandell M; Druker BJ; Gotlib J; O'Hare T; Deininger MW
Leukemia; 2016 Apr; 30(4):906-13. PubMed ID: 26648538
[TBL] [Abstract][Full Text] [Related]
19. How I diagnose and treat chronic myelomonocytic leukemia.
Patnaik MM
Haematologica; 2022 Jul; 107(7):1503-1517. PubMed ID: 35236051
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients from Puerto Rico.
Jiang Z; Sun X; Wu Z; Alhatem A; Zheng R; Liu D; Wang Y; Kumar D; Xia C; You B; Wang H; Liu C; Jiang JG
Oncotarget; 2020 Nov; 11(47):4411-4420. PubMed ID: 33315966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
